Stem Cells From Deceased Donors; Cancer Screening Lags; Blood Type and Cancer Risk



(MedPage Today) — A first-of-its-kind clinical trial will evaluate stem cell transplants with cells from deceased donors. (University of Utah Huntsman Cancer Institute)
Will President Trump’s executive order to lower drug prices wreak “enormous…



Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/115623

Author :

Publish date : 2025-05-16 17:30:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version